Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530163 · ClinicalTrials.gov registry record · NA
Breathing Training to Improve Human Performance at High Altitude
A NA study of Mountain Sickness Acute, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03530163 is a NA study of Mountain Sickness Acute that has completed, run by University of Colorado, Denver. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03530163, a NA study of Mountain Sickness Acute, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals traveling to altitudes above 8,000 feet may suffer from impaired exercise and cognitive performance, and acute mountain sickness (AMS). Decreased barometric pressure, which leads to low blood oxygen levels, is the primary cause of these disorders. Symptoms of AMS are characterized by headache, nausea, vomiting, dizziness, fatigue, and difficulty sleeping. The goal of this research is to identify whether Respiratory Muscle Training will improve physical and cognitive performance, and reduce the symptoms of AMS, at simulated high altitude.
Conditions Studied
Interventions
- DEVICE Respiratory Muscle Training
- DEVICE Sham Breathing Training
Study Locations (1)
Colorado
- Altitude Research Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-08-09 |
| Est. Completion | 2020-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03530163
The ClinicalTrials.gov registry entry for NCT03530163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mountain Sickness Acute appearing as the primary indexed condition, and to 2 interventions - of which Respiratory Muscle Training is the first listed.
NCT03530163 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03530163 about?
NCT03530163 is a clinical study titled "Breathing Training to Improve Human Performance at High Altitude". Individuals traveling to altitudes above 8,000 feet may suffer from impaired exercise and cognitive performance, and acute mountain sickness (AMS). Decreased barometric pressure, which leads to low blood oxygen levels, is the primary cause of these disorders. Symptoms of AMS are characterized by hea...
What is the current status of trial NCT03530163?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-08-09. Estimated completion is 2020-01-15.
What conditions does trial NCT03530163 study?
This clinical trial studies the following conditions: Mountain Sickness Acute.
What interventions are being tested in trial NCT03530163?
The interventions under investigation include: Respiratory Muscle Training (DEVICE), Sham Breathing Training (DEVICE).
Who is sponsoring clinical trial NCT03530163?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03530163 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.